Diebold Nixdorf Inc(DBD)
$57.04-0.30 (-0.52%)
DBD
Diebold Nixdorf Inc financials statements
$57.04
At close:-0.30 (-0.52%)
Want to see DBD full AI Analyst Report?
Diebold Nixdorf Inc (DBD) Ratios
98 Followers
Diebold Nixdorf Inc Ratios
DBD's free cash flow for Q3 2026 was $-60.30M. For the 2026 fiscal year, DBD's free cash flow was decreased by $-12.90M and operating cash flow was $-47.40M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.30 | 1.32 | 1.52 | 1.10 | 1.08 |
| Quick Ratio | 0.92 | 0.90 | 1.10 | 0.74 | 0.77 |
| Cash Ratio | 0.28 | 0.23 | 0.39 | 0.19 | 0.22 |
| Solvency Ratio | 0.08 | 0.04 | 0.49 | -0.10 | 0.02 |
| Operating Cash Flow Ratio | 0.22 | 0.12 | -0.18 | -0.24 | 0.07 |
| Short-Term Operating Cash Flow Coverage | 5.81 | 746.00 | -856.67 | -16.16 | 2.62 |
| Net Current Asset Value | $ -962.80M | $ -937.40M | $ -928.90M | $ -2.67B | $ -2.46B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.30 | 0.30 | 0.33 | 0.89 | 0.70 |
| Debt-to-Equity Ratio | 1.07 | 1.13 | 1.28 | -1.97 | -2.90 |
| Debt-to-Capital Ratio | 0.52 | 0.53 | 0.56 | 2.03 | 1.53 |
| Long-Term Debt-to-Capital Ratio | 0.48 | 0.50 | 0.54 | 2.15 | 1.60 |
| Financial Leverage Ratio | 3.50 | 3.81 | 3.91 | -2.22 | -4.15 |
| Debt Service Coverage Ratio | 2.26 | 1.74 | 0.81 | -1.18 | 1.10 |
| Interest Coverage Ratio | 3.90 | 1.17 | 0.35 | -1.06 | 0.70 |
| Debt to Market Cap | 0.43 | 0.57 | 0.67 | 1.61 | 1.42 |
| Interest Debt Per Share | 34.23 | 31.98 | 24.92 | 37.02 | 33.79 |
| Net Debt to EBITDA | 2.35 | 2.24 | 2.94 | -21.32 | 7.02 |
| Profitability Margins | |||||
| Gross Profit Margin | 26.37% | 24.53% | 23.30% | 21.88% | 26.72% |
| EBIT Margin | 5.45% | 5.40% | 3.95% | -6.92% | 3.70% |
| EBITDA Margin | 8.80% | 8.93% | 7.31% | -3.28% | 7.52% |
| Operating Profit Margin | 8.79% | 4.85% | 2.31% | -6.12% | 3.51% |
| Pretax Profit Margin | 3.20% | 1.33% | 38.62% | -12.61% | -1.29% |
| Net Profit Margin | 2.49% | -0.44% | 36.59% | -16.80% | -2.02% |
| Continuous Operations Profit Margin | 2.56% | -0.39% | 36.61% | -16.92% | -2.00% |
| Net Income Per EBT | 77.80% | -33.13% | 94.75% | 133.23% | 156.35% |
| EBT Per EBIT | 36.34% | 27.35% | 1671.23% | 206.14% | -36.76% |
| Return on Assets (ROA) | 2.45% | -0.47% | 33.06% | -18.97% | -2.25% |
| Return on Equity (ROE) | 8.60% | -1.77% | 129.36% | 42.10% | 9.32% |
| Return on Capital Employed (ROCE) | 13.48% | 8.00% | 3.17% | -14.50% | 7.80% |
| Return on Invested Capital (ROIC) | 10.58% | -2.28% | 2.96% | -13.90% | 7.37% |
| Return on Tangible Assets | 3.91% | -0.76% | 51.76% | -27.62% | -3.26% |
| Earnings Yield | 3.79% | -1.02% | 73.86% | -35.78% | -4.89% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.24 | 6.37 | 5.21 | 5.65 | 6.56 |
| Payables Turnover | 6.50 | 6.15 | 5.45 | 4.42 | 4.05 |
| Inventory Turnover | 5.38 | 5.36 | 4.89 | 4.60 | 5.26 |
| Fixed Asset Turnover | 12.22 | 15.24 | 14.59 | 15.11 | 13.44 |
| Asset Turnover | 0.99 | 1.06 | 0.90 | 1.13 | 1.11 |
| Working Capital Turnover Ratio | 9.32 | 6.61 | 8.37 | 22.78 | 22.59 |
| Cash Conversion Cycle | 70.16 | 66.02 | 77.75 | 61.40 | 34.96 |
| Days of Sales Outstanding | 58.45 | 57.26 | 70.06 | 64.57 | 55.63 |
| Days of Inventory Outstanding | 67.86 | 68.09 | 74.64 | 79.40 | 69.41 |
| Days of Payables Outstanding | 56.15 | 59.33 | 66.94 | 82.58 | 90.08 |
| Operating Cycle | 126.31 | 125.35 | 144.70 | 143.97 | 125.04 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 8.17 | 3.97 | -3.99 | -4.91 | 1.57 |
| Free Cash Flow Per Share | 7.15 | 3.51 | -4.38 | -5.58 | 0.92 |
| Dividend Paid and CapEx Coverage Ratio | 8.04 | 8.57 | -10.32 | -7.31 | 2.40 |
| Capital Expenditure Coverage Ratio | 8.04 | 8.57 | -10.32 | -7.31 | 2.40 |
| Operating Cash Flow Coverage Ratio | 0.26 | 0.14 | -0.19 | -0.14 | 0.05 |
| Operating Cash Flow to Sales Ratio | 0.08 | 0.04 | -0.07 | -0.11 | 0.03 |
| Free Cash Flow Yield | 10.54% | 8.14% | -15.13% | -27.14% | 4.47% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 26.42 | -98.08 | 1.35 | -2.80 | -20.44 |
| Price-to-Sales (P/S) Ratio | 0.66 | 0.43 | 0.50 | 0.47 | 0.41 |
| Price-to-Book (P/B) Ratio | 2.27 | 1.74 | 1.75 | -1.18 | -1.91 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 9.49 | 12.28 | -6.61 | -3.68 | 22.37 |
| Price-to-Operating Cash Flow Ratio | 8.31 | 10.85 | -7.25 | -4.19 | 13.06 |
| Price-to-Earnings Growth (PEG) Ratio | -0.04 | 0.96 | -0.00 | -0.00 | 0.29 |
| Enterprise Value Multiple | 9.81 | 7.07 | 9.71 | -35.65 | 12.50 |
| Enterprise Value | 3.29B | 2.37B | 2.67B | 4.04B | 3.67B |
| EV to EBITDA | 9.81 | 7.07 | 9.71 | -35.65 | 12.50 |
| EV to Sales | 0.86 | 0.63 | 0.71 | 1.17 | 0.94 |
| EV to Free Cash Flow | 12.48 | 17.98 | -9.47 | -9.17 | 51.00 |
| EV to Operating Cash Flow | 10.93 | 15.88 | -10.39 | -10.42 | 29.78 |
| Tangible Book Value Per Share | -8.97 | -11.35 | -6.59 | -29.51 | -24.62 |
| Shareholders’ Equity Per Share | 29.89 | 24.73 | 16.53 | -17.48 | -10.79 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 1.29 | 0.05 | -0.34 | -0.55 |
| Revenue Per Share | 103.42 | 99.76 | 58.43 | 43.81 | 49.87 |
| Net Income Per Share | 2.57 | -0.44 | 21.38 | -7.36 | -1.01 |
| Tax Burden | 0.78 | -0.33 | 0.95 | 1.33 | 1.56 |
| Interest Burden | 0.59 | 0.25 | 9.77 | 1.82 | -0.35 |
| Research & Development to Revenue | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 |
| SG&A to Revenue | 0.15 | 0.17 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 3.18 | -10.29 | -0.19 | 0.66 | -1.56 |
Currency in USD
